Document
IPR2024-00631, No. 1018 Exhibit - 1018 Banting, The Internal Secretion of the Pancreas, 7 J LAB CLINICAL ME (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1018 Exhibit - 1018 Banting, The Internal Secretion of the Pancreas, 7 J LAB CLINICAL ME (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1504 Exhibit - 1504 CV of Mark J Ratain, MD (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1504 Exhibit - 1504 CV of Mark J Ratain, MD (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1049 Exhibit - 1049 International Conference on Harmonisation Dose Response Information t (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1049 Exhibit - 1049 International Conference on Harmonisation Dose Response Information t (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1024 Exhibit - 1024 Drucker, The Incretin System Glucagon Like Peptide 1 Receptor Agonist (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1024 Exhibit - 1024 Drucker, The Incretin System Glucagon Like Peptide 1 Receptor Agonist (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1029 Exhibit - 1029 Jimenez Solem, Dulaglutide, a Long Acting GLP1 Analog Fused with an F (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1029 Exhibit - 1029 Jimenez Solem, Dulaglutide, a Long Acting GLP1 Analog Fused with an F (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1004 Exhibit - CV of John Bantle, MD (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1004 Exhibit - CV of John Bantle, MD (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1057 Exhibit - 1057 WO 2011073328 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1057 Exhibit - 1057 WO 2011073328 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1011 Exhibit - 1011 WO 2011138421 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1011 Exhibit - 1011 WO 2011138421 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1084 Exhibit - 1084 EMA, ICH Topic S 7 A Safety Pharmacology Studies for Human Pharmaceuti (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1084 Exhibit - 1084 EMA, ICH Topic S 7 A Safety Pharmacology Studies for Human Pharmaceuti (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1020 Exhibit - 1020 Bydureon prescribing information Jan 2012 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1020 Exhibit - 1020 Bydureon prescribing information Jan 2012 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 2001 Exhibit - EX2001 Docket Sheet from PTACTS, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724 (P.T.A.B. Jun. 12, 2024)
Cite Document
IPR2024-00631, No. 2001 Exhibit - EX2001 Docket Sheet from PTACTS, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724 (P.T.A.B. Jun. 12, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1016 Exhibit - 1016 US Patent Application Pub No US20070010424 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1016 Exhibit - 1016 US Patent Application Pub No US20070010424 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1031 Exhibit - 1031 Knudsen, GLP1 Derivatives as Novel Compounds for the Treatment of Typ (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1031 Exhibit - 1031 Knudsen, GLP1 Derivatives as Novel Compounds for the Treatment of Typ (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Mar. 11, 2024)
Cite Document
IPR2024-00631, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Mar. 11, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1072 Exhibit - 1072 US Patent No 5,164,366 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1072 Exhibit - 1072 US Patent No 5,164,366 (P.T.A.B. Mar. 1, 2024)
+ More Snippets